Opioid Dependence: Clinical Trials

160 trials for Opioid Dependence, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

108 completed, 17 unknown, 12 terminated, 9 recruiting. 45 Not applicable, 38 Phase 2, 27 Phase 3, 22 Phase 1, 18 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable45Completed 26, Unknown 8, Terminated 4, Withdrawn 3, Active not recruiting 2, Recruiting 2
Phase 238Completed 30, Terminated 3, Unknown 3, Active not recruiting 1, Recruiting 1
Phase 327Completed 20, Unknown 3, Withdrawn 2, Active not recruiting 1, Terminated 1
Phase 122Completed 19, Active not recruiting 1, Not yet recruiting 1, Recruiting 1
Phase 418Completed 10, Recruiting 3, Terminated 3, Unknown 1, Withdrawn 1
Early Phase 16Completed 3, Recruiting 1, Terminated 1, Withdrawn 1

Follow Opioid Dependence: new trials by email Literature Review of Opioid Dependence trials Research Report on Opioid Dependence

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
VK4-116 Phase I Study With Food-Effect
VK4-116, Placebo - Opioid Dependence, Opioid Use Disorder (OUD)
Phase 1Not yet recruitingNational Institute on Drug Abuse (NIDA)482026-08-012026-04-09
Transcranial Direct Current Stimulation (tDCS) for Treatment of Substance Use Disorder
Transcranial Direct Current Stimulator (tDCS), Cognitive Reappraisal Training - Cocaine Use Disorder, Cocaine Dependence
Not applicableRecruitingIcahn School of Medicine at Mount Sinai2402026-02-252026-10-13
Assessing the Acceptability, Feasibility, Effectiveness and Cost-effectiveness of LADB
long-acting depot buprenorphine (LADB) - Opioid Dependence
Not yet recruitingPATH7602025-11-012025-10-07
Standardized Natural Psilocybin-assisted Psychotherapy for Tapering of Opioid Medication
Psilocybin-assisted Psychotherapy - Opioid Dependence, Chronic Pain
Phase 2RecruitingUniversity of British Columbia102025-10-272025-12-04
Better Options for Chronic Cancer Pain
Multimodal pain care, Medication optimization, Buprenorphine rotation - Chronic Pain, Cancer Survivor
Phase 4RecruitingVA Office of Research and Development2942025-10-072026-05-11
Buprenorphine as a Post-operative Analgesic in Opioid-Naive Patients After Ankle Fracture Surgery
Buprenorphine Transdermal System, Placebo Patch - Pain, Postoperative, Ankle Fracture Surgery
Phase 4RecruitingJenna-Leigh Wilson1002025-04-212026-04-06
The MOUD Plus Pilot: Counseling and Peer Support to Support Retention for Medically Complex Patients With Opioid Use Disorder Seen In Primary Care
MOUD "Plus" Intervention (treatment as usual + coordinated counseling and referral to community based peer), Treatment As Usual (primary care with low threshold MOUD prescribing) - Opioid Dependence, Substance Abuse Disorders
Not applicableActive not recruitingOregon Health and Science University702025-03-242026-10-21
fMRI and Opioid Abstinence
fMRI - Drug Use Disorder, Opioid Dependence
RecruitingYale University2402024-12-122026-08-07
A Clinical Trial to Assess Pharmacokinetic Profiles, Safety and Tolerability of IVL3004 and IVL4002 in Healthy Male Subjects.
Vivitrol Injectable Product, IVL3004, IVL4002 - Opioid Dependence, Alcohol Dependence
Phase 1RecruitingInventage Lab., Inc.402024-09-112025-09-15
Gut Microbiota Dysbiosis in Opioid Use Disorders: Implications for Clinical Symptoms and Relapse Rate.
stool analysis - Opioid Use, Opioid Use Disorder
UnknownAssiut University522024-02-012024-01-30
DE-eSCALation of Opioids Post-surgical dischargE
Rapid Opioid de-escalation, Gradual Opioid de-escalation, Continuation of opioids - Opioid Dependence
Not applicableUnknownUniversity of Kent1002024-01-112024-05-02
OLP to Manage Pain in TJA: A Feasibility Study
Open Label Placebo, Patient medication as standardly prescribed - Opioid Dependence, Opioid Abuse
Early Phase 1WithdrawnUniversity of Alabama at Birmingham2023-12-012025-05-13
Exploratory Dose Ranging Study Assessing APH-1501 for the Treatment of Opioid Addiction
APH-1501, Placebo - Addiction, Opioid Dependence
Phase 2UnknownAphios322023-10-012021-07-27
Measuring Acute Drug Demand in Humans
Drug A (Blinded Drug), Drug B (Blinded Drug), Drug C (Blinded Drug) - Opioid Use Disorder, Opioid Dependence
Early Phase 1RecruitingUniversity of Maryland, Baltimore752023-08-082026-06-23
The Effects of Daily Anti-inflammatory Supplementation on Foundation Pain Index Scores in Chronic Opiate Patients
Root.Health Dietary Supplement - Pain, Chronic, Opioid Dependence
Not applicableTerminatedHudson Medical12023-07-102025-03-13
STTEPP: Safety, Tolerability and Dose Limiting Toxicity of Lacosamide in Patients With Painful Chronic Pancreatitis
Lacosamide - Chronic Pain, Chronic Pain Syndrome
Phase 1Active not recruitingIndiana University212023-03-172026-06-03
Novel Induction to Buprenorphine/Naloxone
buprenorphine/naloxone - Opioid Use Disorder, Opioid Use
Phase 4TerminatedBicycle Health332023-02-062024-08-20
Effects on Mortality and Clinical Course of a Patient's Choice Model for Opioid Maintenance Treatment for Opioid Dependence - Evaluation of a System Enabling a Large Expansion of Treatment Providers and Treatment Access
Opioid maintenance treatment - Opioid Dependence, Overdose
UnknownRegion Skane25002023-01-312023-01-10
Return to Work - Will Brief Intervention Reduce Opioid-induced Back Pain?
Brief Intervention - Opioid Dependence, Low Back Pain
Not applicableUnknownUniversity Hospital, Akershus102022-08-012022-06-29
Brain Mechanisms of Pharmacotherapy in Opioid Use Disorder
Brixadi, Vivitrol - Opioid Dependence
Phase 2TerminatedUniversity of Pennsylvania32022-08-012025-08-06

Showing 20 of 160. Sign in to see all of them.

Narrower conditions

Opioid-Related Disorders (160)  ·  Substance-Related Disorders (15)  ·  Chronic Pain (14)  ·  Behavior, Addictive (13)  ·  Pain (10)  ·  Cocaine-Related Disorders (9)  ·  Heroin Dependence (6)  ·  Pain, Postoperative (5)  ·  Acquired Immunodeficiency Syndrome (4)  ·  Agnosia (3)  ·  Osteoarthritis, Knee (3)  ·  Alcoholism (2)  ·  Contraception Behavior (2)  ·  Depression (2)  ·  Drug Overdose (2)

Broader conditions

Chemically-Induced Disorders (160)  ·  Narcotic-Related Disorders (160)  ·  Mental Disorders (159)  ·  Substance-Related Disorders (145)  ·  Pathological Conditions, Signs and Symptoms (33)  ·  Neurologic Manifestations (27)  ·  Signs and Symptoms (27)  ·  Behavior (20)  ·  Pain (15)  ·  Compulsive Behavior (13)  ·  Impulsive Behavior (13)  ·  Pathologic Processes (13)  ·  Infections (9)  ·  Urogenital Diseases (9)  ·  Communicable Diseases (8)

Interventions

Buprenorphine (19)  ·  Buprenorphine, Naloxone Drug Combination (18)  ·  vivitrol (10)  ·  Methadone (8)  ·  Naltrexone (8)  ·  lofexidine (5)  ·  Gabapentin (4)  ·  Therapeutics (4)  ·  Memantine (3)  ·  Opiate Substitution Treatment (3)  ·  Oxycodone (3)  ·  Heroin (2)  ·  Hydromorphone (2)  ·  Isradipine (2)  ·  Methods (2)

Sponsors

New York State Psychiatric Institute (11)  ·  Yale University (11)  ·  Johns Hopkins University (10)  ·  University of Pennsylvania (6)  ·  NYU Langone Health (5)  ·  Indivior Inc. (4)  ·  National Institute on Drug Abuse (NIDA) (4)  ·  Titan Pharmaceuticals (4)  ·  USWM, LLC (dba US WorldMeds) (4)  ·  BioDelivery Sciences International (3)  ·  Brigham and Women's Hospital (3)  ·  University of Arkansas (3)  ·  University of British Columbia (3)  ·  Alkermes, Inc. (2)  ·  Baylor College of Medicine (2)

Countries

United States (122)  ·  Canada (6)  ·  Australia (3)  ·  Malaysia (2)  ·  Norway (2)  ·  Sweden (2)  ·  Switzerland (2)  ·  Austria (1)  ·  China (1)  ·  Germany (1)  ·  Iran (1)  ·  Spain (1)  ·  Ukraine (1)  ·  United Kingdom (1)  ·  Vietnam (1)

Top investigators

Alison Oliveto, Ph.D. (3)  ·  Charles W Gorodetzky, MD, PhD (3)  ·  James A Longstreth, PhD (3)  ·  Adam Bisaga, M.D. (2)  ·  Adam Bisaga, MD (2)  ·  Elias Dakwar, MD (2)  ·  Kenneth Silverman, Ph.D. (2)  ·  Sarah H. Heil, Ph.D. (2)  ·  Adam Hanina, MBA, MPhil (1)  ·  Adeeba Kamarulzaman, MBBS (1)  ·  Alaa El-Din Darwish Othman, professor (1)  ·  Alain Litwin, MD (1)  ·  Alexander Wong, MD (1)  ·  Alexandra Hajduk, PhD (1)  ·  Alison Oliveto, PhD (1)

Results publications

PMID 40342086, PMID 10870744, PMID 11058673, PMID 11165371, PMID 11786502, PMID 12873949, PMID 14621285, PMID 1517644, PMID 15647484, PMID 15800228, PMID 15919269, PMID 16002025, PMID 16487223, PMID 16508405, PMID 16887281, PMID 17084789, PMID 17123731, PMID 17237664, PMID 17341537, PMID 17433624, PMID 17523584, PMID 17624688, PMID 17635557, PMID 17853395, PMID 17907858, PMID 17931826, PMID 18068905, PMID 18294378, PMID 18362258, PMID 18378801, PMID 18419722, PMID 18619874, PMID 18774343, PMID 19409861, PMID 19789074, PMID 20031953, PMID 20086062, PMID 20940383, PMID 21029787, PMID 21142534, PMID 21148579, PMID 21249671, PMID 21317588, PMID 21317589, PMID 21317590, PMID 21317591, PMID 21317592, PMID 21317595, PMID 21317596, PMID 21317597

NIH funding

U01DA030916 (3), R01DA010017 (2), 1RM1DA055310-01 (1), 2016 (1), 3UG1DA040316-06S4 (1), I01CX002902 (1), K02DA032322 (1), K23DA000429 (1), K23DA021209 (1), K23DA029609 (1), K23DA053390 (1), KL2TR002530 (1), P30DK072488 (1), P50DA009236 (1), P50DA009241 (1)